Labcorp (LH) EVP Brian Caveney Receives Restricted Stock Award

What Happened Brian J. Caveney, Executive Vice President, President of BLS, and Labcorp's Chief Medical Officer & Chief Scientific Officer, was granted 3,000 restricted stock units (RSUs) on September 1, 2026. The grant is recorded at $0.00 per unit (no cash exchanged); total reported value $0 because this is an equity award (derivative) representing the right to receive shares in the future.

Key Details

• Transaction date: 2026-09-01; Filing date: 2026-09-03 (appears timely within the SEC two-business-day window).
• Award: 3,000 Restricted Stock Units (RSUs) @ $0.00 per unit; reported aggregate held after grant: 3,000 RSUs.
• Footnotes: F1—Each RSU equals the contingent right to one share of Labcorp common stock. F2—RSUs vest in three equal annual installments beginning September 1, 2027. F3—3,000 reflects the aggregate number of RSUs held by the reporting person.
• Transaction code: A (award/grant).

Context This was an equity award, not an open-market purchase or sale; RSUs vest over time and do not represent immediately tradable shares. Such grants are common for executive compensation and indicate future potential share delivery rather than an immediate market vote.